Login

Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Why I Chose Financial Planning: My Journey and Passion
00:10:00
Tamboran Resources Begins Drilling in Beetaloo Basin, Secures Final Regulatory Approvals
00:10:00
Maximizing Returns and Managing Risks in Mutual Funds | Nimesh Shah, CEO , ICICI Prudential Mutual Fund .
00:10:00
John Devaney, founder and CEO of United Capital Markets, appears on 'Squawk' to discuss market insights.
00:10:00
Exploring Hubbster's SaaS Platform and Newbury's Pharmaceutical Growth | Lars Minor, CEO , Polymetals Resources Ltd.
00:10:00
Scale needs to be achieved quickly but also correctly|Roseanne Wincek,Co-Founder and Managing Director,Renegade Partners
00:10:00
Navigating Raw Material Challenges: Tire Industry Demand and Growth Outlook for 2023|Mr. Suresh Sodani,Managing Director,Century Enka Ltd
00:10:00
AirAsia Boss Tony Fernandes on Elevating Passenger Experience and Embracing Digital Transformation | Tony Fernandes, CEO, AirAsia Bhd.
00:10:00
Specializes in game developers|Ed Fries,General Partner,1Up Ventures
00:10:00
Borosil's Business Restructuring: CEO Shreevar Kheruka Discusses Consumer Business Spin-Off | Shreevar Kheruka, CEO, Borosil Ltd.
00:10:00
Alaska Airlines CEO Ben Minicucci on Q2 Earnings Loss and Strategic Tech Investments | Ben Minicucci, CEO, Alaska Airlines.
00:00:00
Tal Yalon, M.D., Mayo Clinic

© 2017 - Neuhu+